Skip to main content

Ayan

Analyst

Cantor Fitzgerald (on behalf of Kristen Kluska)

Equibles does not estimate personal net worth.

About Ayan

Ayan is recorded as Analyst at Cantor Fitzgerald (on behalf of Kristen Kluska). Ayan has spoken on 1 earnings call across 1 company, most recently for Zevra Therapeutics, Inc. on May 6, 2026. The companies whose calls Ayan spoke on are classified in the Healthcare sector.

Ayan on recent calls

“First, now that my PIFAR has been added to the NPC clinical practice guidelines, we're just wondering what this means for physician adoption. Are these doctors now formally advised to consider my PIFAR when treating these patients?”
Analyst — Cantor Fitzgerald (on behalf of Kristen Kluska), Zevra Therapeutics, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Cantor Fitzgerald (on behalf of Kristen Kluska)

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity